Predictive modeling determined that the needle exchange in Washington, DC, prevented 120 new cases of HIV in 2 years, according to researchers.
Needle exchanges can prevent new cases of HIV, according to a new study published in AIDS and Behavior. After Washington, DC, lifted the ban on spending city money on needle exchanges, the researchers used a modeling technique to predict how many HIV infections would have occurred if the ban remained. They determined that the needle exchange prevented 120 new cases in 2 years.
Intravenous drug users can trade dirty syringes for clean ones at needle exchanges, which have been controversial programs to implement and spend city money on. While proponents claim needle exchanges curb the spread of HIV, opponents argue that the existence of these programs enable addicts to keep using.
In 1988, Congress banned the use of federal funds for needle exchanges. However, the District of Columbia was unable to use its own money until 2007, because Congress oversees its budget. The DC ban was lifted in late 2007 and the needle exchange program was implemented.
Read more at USA Today: http://usat.ly/1IN4e0B
Ruxolitinib Cream Shows Long-Term Safety in AD, Potential for PN Treatment
March 8th 2025Two posters presented at the 2025 American Academy of Dermatology Annual Meeting reaffirmed the impact of ruxolitinib cream (Opzelura; Incyte) in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN).
Read More
Demographic Disparities in Video Visit Telemetry: Understanding Telemedicine Utilization
March 7th 2025A stratified demographics analysis of video visit telemetry data reveals that age older than 65 years and African American/Black race are associated with higher video visit failure rates, whereas language, sex, and ethnicity are not.
Read More
Reducing Readmissions in the Safety Net Through AI and Automation
March 6th 2025Artificial intelligence (AI) and electronic health record–based automation tools helped a safety-net health system meet performance-based readmission metrics, thereby retaining critical funding while improving clinical and equity outcomes.
Read More